Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2006-07-18
2006-07-18
Navarro, Mark (Department: 1645)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S388100, C530S388400, C435S007100
Reexamination Certificate
active
07078492
ABSTRACT:
The invention described herein provides human antibodies produced in non-human animals that specifically bind toStreptococcus pneumoniaecapsular polysaccharide (PPS-3). The invention further provides methods for making the antibodies in a non-human animal and for expressing the antibodies in cells including hybridomas and recombinant host cell systems. Kits and pharmaceutical compositions comprising the antibodies are also provided in addition to methods of treating, inhibitng or preventingS. pneumoniaeinfection or conditions or disorders caused by such infection by administering to a patient the pharmaceutical compositions described herein.
REFERENCES:
patent: 4399216 (1983-08-01), Axel et al.
patent: 4510245 (1985-04-01), Cousens et al.
patent: 4634665 (1987-01-01), Axel et al.
patent: 4740461 (1988-04-01), Kaufman
patent: 4912040 (1990-03-01), Kaufman et al.
patent: 4959455 (1990-09-01), Clark et al.
patent: 4968615 (1990-11-01), Koszinowski et al.
patent: 5168062 (1992-12-01), Stinski
patent: 5179017 (1993-01-01), Axel et al.
patent: 5741957 (1998-04-01), Deboer et al.
patent: 5750172 (1998-05-01), Meade et al.
patent: 5756687 (1998-05-01), Denman et al.
patent: 5827690 (1998-10-01), Meade et al.
patent: 5916771 (1999-06-01), Hori et al.
patent: 5939598 (1999-08-01), Kucherlapati et al.
patent: 5985615 (1999-11-01), Jakobovits et al.
patent: 5998209 (1999-12-01), Jokobovits et al.
patent: 6075181 (2000-06-01), Kucherlapati et al.
patent: 6091001 (2000-07-01), Jakobovits et al.
patent: 6114598 (2000-09-01), Kucherlapati et al.
patent: 6130364 (2000-10-01), Jakobovits et al.
patent: 0 216 846 (1990-01-01), None
patent: 0 256 055 (1991-08-01), None
patent: 0 323 997 (1993-04-01), None
patent: 0 338 841 (1995-03-01), None
patent: WO 91/10741 (1991-07-01), None
patent: WO 94/02602 (1994-02-01), None
patent: WO 96/33735 (1996-10-01), None
patent: WO 96/34096 (1996-10-01), None
patent: WO 98/16654 (1998-04-01), None
patent: WO 98/24893 (1998-06-01), None
patent: WO 98/50433 (1998-11-01), None
patent: WO 99/45031 (1999-09-01), None
patent: WO 99/53049 (1999-10-01), None
patent: WO 00/09560 (2000-02-01), None
patent: WO 00/037504 (2000-06-01), None
Abadi, J. et al., “Human Antibodies Elicited by a Pneumococcal Vaccine Express Idiotypic Determinants Indictive of VH3 Gene Segment Usage,”J. Infect. Dis.178:707-716 (1998).
Bowie, J.U., et al., “A Method to Identify Protein Sequences That Fold Into a Known Three-Dimensional Structure,”Science. 253:164-170 (1991).
Chothia, C. & Lesk, A.M., “Canonical Structures for the Hypervariable Regions of Immunoglobulins,”J. Mol. Biol.196:901-917 (1987).
Chothia, C., et al., “Conformations of Immunoglobulin Hypervariable Regions,”Nature342:877-883 (1989).
Green, L.L. & Jakobovits, A., “Regulation of B Cell development by Variable Gene Complexity in Mice Reconstituted with Human Immunoglobulin Yeast Artificial Chromosomes,”J. Exp. Med.188:483-495 (1998).
Green, L.L., et al., “Antigen-Specific Human Monoclonal Antibodies from Mice Engineered with Human Lg Heavy and Light Chain Yacs,”Nature Genet.7:13-21 (1994).
Holliger, P., et al., “‘Diabodies’: Small Bivalent and Bispecific Antibody Fragments,”Proc. Natl. Acad. Sci. U.S.A.90:6444-6448 (1993).
Johnson, G & Wu, T.T., “Kabat Database and its Applications: Future Directions,”Nucl. Acids Res.29:205-206 (2001).
Kaufman, R.J. and Sharp, P.A., “Amplification and Expression of Sequences Contransfected with a Modular Dihydrofolate Reductase Complementary DNA Gene,”J. Mol. Biol.159:601-621 (1982).
Kostelny, S.A., et al., “Formation of a Bispecific Antibody by the Use of Leucine Zippers,”J. Immunol.148:1547-1553 (1992).
McCormick, L.L., et al., “Bispecific Antibodies Overcome the Opsonin-Receptor Mismatch of Cystic Fibrosis In Vitro: Restoration of Neutrophil-Mediated Phagocytosis and Killing ofPseudomonas aeruginosa,”J Immunol.158:3474-82 (1997).
Mendez, M.J., et al., “Functional Transplant of Megabase Human Immunoglobulin Loci Recapitulates Human Antibody Response in Mice,”Nat. Genet.15, pp. 146-156 (1997).
Mukherjee, J. et al., Molecular Characterization of the Humoral Responses toCryptococcus neoformansInfection and Glucuronoxylomannan- Tetanus Toxoid Conjugate Immunization,J. Exp. Med.177:1105-1116 (1993).
Pirofski, L., et al., “Analysis of Human Monoclonal Antibodies Elicited by Vaccination,”Infect. Immun.63:3005-3014 (1995) andInfect. Immun.68:1820-1826 (2000).
Russell, N.D., et al., “Production of Protective Human Antipneumococcal Antibodies by Transgenic Mice with Human Immunoglobulin Loci,”Infection Immunity68:1820-1826 (2000).
Russell, N.D., et al., A Tale of Two Pathogens: Human Antibody Immunity toCrypotococcus neoformansandStreptococcus pneumoniae, Einstein Quart. J. Biol. Med.15:148-157 (1998).
Songsilvllai, S. & Lachmann, P.C., “Bispecific antibody: a tool for diagnosis and treatement of disease,”Clin. Exp. Immunol.79:315-321 (1990).
Thornton, J.M., et al., “Prediction of progress at last,”Nature354:105-106 (1991).
Traunecker, A., et al., “Bispecific single chain molecules (Janusins) target cytotoxic lymphocytes on HIV infected cells,”EMBO J.10:3655-3659 (1991).
Traunecker, A., et al., “Janusin: New molecular design for bispecific reagents,”Int. J. Cancer Suppl.7:51-52 (1992).
Chang Qing
Pirofski Liise-anne
Zhong Zhaojing
Abgenix, Inc.
Banerjee Shilpi
Fish & Neave IP Group of Ropes & Gray LLP
Gunnison Jane T.
Navarro Mark
LandOfFree
Human antipneumococcal antibodies from non-human animals does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human antipneumococcal antibodies from non-human animals, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human antipneumococcal antibodies from non-human animals will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3578817